Kidney cancer, Renal cell cancer
Results
Phase 2
This trial looked at a combination of the chemotherapy drugs irinotecan, cisplatin and mitomycin C (IPM) for advanced kidney cancer. Advanced kidney cancer means the cancer has spread from where it first developed in the kidney.
Recruitment start: 12 March 2003
Recruitment end: 31 January 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jonathan Shamash
Barts Health NHS Trust
Experimental Cancer Medicine Centre (ECMC)
Orchid Cancer Appeal
Last reviewed: 13 Jan 2016
CRUK internal database number: 2616